Increased thymidine incorporation into fetal rat cartilage in vitro in the presence of human somatomedin, epidermal growth factor and other growth factors.

The incorporation of [3H]thymidine by rat costal cartilage in vitro was studied at different fetal and postnatal ages and the effect of partially purified human somatomedin, mouse epidermal growth factor, platelet secretion products, insulin and growth hormone on thymidine uptake by fetal cartilage was examined. Thymidine uptake in plasma-free medium was many times greater in late fetal life than after birth. The incorporation of [3H]thymidine into costal cartilage from 21-day fetuses was significantly (P less than 0.05) increased above control values in the presence of 10 micrograms somatomedin/1, and when cartilage was incubated in medium containing somatomedin and diluted human plasma there was a synergistic action. Epidermal growth factor at a concentration of 1 ng/l was a potent stimulator of thymidine uptake. Secretion products from human platelets after their aggregation by thrombin stimulated [3H]thymidine uptake at a concentration of 2% (v/v), but were inhibitory at high concentrations. High concentrations of platelet secretion products stimulated the incorporation of [35S]sulphate by cartilage. A pharmacological concentration of 10 mu. insulin/ml stimulated [3H]thymidine uptake, but not concentrations of 1 or 100 mu./ml. Growth hormone had no effect. The results showed that fetal cartilage had a greater endogenous mitogenic activity than postnatal cartilage. While somatomedins may be important in the regulation of fetal body growth, other protein growth factors also stimulate fetal skeletal tissues.

[1]  I. K. Ashton,et al.  Human fetal cartilage response to plasma somatomedin activity in relation to gestational age , 2006, Calcified Tissue International.

[2]  I. K. Ashton,et al.  Change in response with age of human articular cartilage to plasma somatomedin activity , 1979, Calcified Tissue International.

[3]  R. Ross,et al.  Purification of human platelet-derived growth factor. , 1985, Methods in enzymology.

[4]  E. Schoenle,et al.  Insulin-like growth factor I stimulates growth in hypophysectomized rats , 1982, Nature.

[5]  H. Vorherr,et al.  Factors influencing fetal growth. , 1982, American journal of obstetrics and gynecology.

[6]  W. Daughaday,et al.  Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction. , 1982, Endocrinology.

[7]  D. Hill,et al.  Somatomedins and fetal growth. , 1981, Ciba Foundation symposium.

[8]  D. Hill,et al.  Cartilage response to plasma and plasma somatomedin activity in rats related to growth before and after birth. , 1981, The Journal of endocrinology.

[9]  K. Takano,et al.  Changes in serum somatomedin A and its binding to kidney membranes in growing rats. , 1981, Acta endocrinologica.

[10]  E. Adamson,et al.  Functional EGF receptors are present on mouse embryo tissues , 1981, Nature.

[11]  R. Kelch,et al.  Connective tissue activation. XXII. A platelet growth factor (connective tissue-activating peptide-III) in human growth hormone-deficient patients. , 1981, The Journal of clinical endocrinology and metabolism.

[12]  R. Hintz The somatomedins. , 1981, Advances in pediatrics.

[13]  J. Jennings,et al.  Stimulation of chick embryo cartilage sulfate and thymidine uptake: comparison of human serum, purified somatomedins, and other growth factors. , 1980, The Journal of clinical endocrinology and metabolism.

[14]  A. Moses,et al.  Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Hollenberg,et al.  Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. V. Van Wyk,et al.  Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedins. , 1980, Biochemistry.

[17]  R. Hintz,et al.  Increased somatomedin receptor sites in newborn circulating mononuclear cells. , 1979, Journal of Clinical Endocrinology and Metabolism.

[18]  E. Rinderknecht,et al.  Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications. , 1978, Metabolism: clinical and experimental.

[19]  H. D. Mosier,et al.  317 PRESENCE IN RAT SERUM OF AN INHIBITOR OF 3H-THYMIDINE INCORPORATION BY CHONDROCYTES IN VITRO , 1978, Pediatric Research.

[20]  M. Francis,et al.  Response of chondrocytes isolated from human foetal cartilage to plasma somatomedin activity. , 1978, The Journal of endocrinology.

[21]  J. van den Brande,et al.  The Snell-dwarfmouse. II. Sulphate and thymidine incorporation in costal cartilage and somatomedin levels before and during growth hormone and thyroxine therapy. , 1978, Acta endocrinologica.

[22]  A. Mescher,et al.  A comparison of the responses of cultured myoblasts and chondrocytes to fibroblast and epidermal growth factors , 1977, Journal of cellular physiology.

[23]  Ritchie Jc,et al.  Connective tissue activation. XI. Stimulation of glycosaminoglycan and DNA formation by a platelet factor. , 1977 .

[24]  G. Beaton Studies on serum somatedin activity and cartilage responsiveness in the regulation of growth , 1976 .

[25]  M. Pandian,et al.  Cellular and molecular correlates of the decline in responsiveness of cartilage and thymus to growth hormone in aged animals , 1974 .

[26]  M. Solursh,et al.  Stimulation of sulfate incorporation by growth hormone treatment of cultured chick embryo chondrocytes. , 1972, General and comparative endocrinology.

[27]  W. Daughaday,et al.  Synchronous activation of DNA synthesis in hypophysectomized rat cartilage by growth hormone. , 1966, The Journal of laboratory and clinical medicine.